The leadership team at Brainstorm Cell Therapeutics has a history of experience in the pharmaceutical industry, academia, and government affairs. The team is led by a senior director with experience in government affairs, advocacy, and communications from Mitsubishi Tanabe Pharma America and Bristol-Myers Squibb. The team also includes an academic affairs and networks project leader from Teva Pharmaceuticals, a senior scientist and study director from Crown Bioscience, Inc., and a scientific advisor from ImmunoHiTech LTD. The team's education histories include degrees from the University of Oregon in political science and history, Tel Aviv University in clinical biochemistry, and Bar-Ilan University in immuno-oncology and personalized medicine.
Alex Burshtein
Quality Assurance Manager
Arturo Araya
Chief Commercial Officer
Chaim Lebovits
President & CEO
Eyal Rubin
EVP, Chief Financial Officer
Mary Kay Turner
VP of Patient Advocacy and Gov...
Ralph Kern
Chief Operating Officer and Ch...
Revital Aricha
VP Research & Development
Susan E. Ward
Head Of Clinical Operations
Uri Yablonka
EVP, Chief Business Officer
Yael Gothelf
Vp Scientific And Regulatory A...
Yossef Levy
VP Cell Production
View all